Bausch & Lomb Inc

Type: Company
Name: Bausch & Lomb Inc (Bausch & Lomb Incorporated)
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Second to none

In importance to the Rochester-area economy, non-profits today are second to none. Indeed, measured by employment and the rate of jobs created, these businesses have taken on the leading role.Look at this week’s RBJ 75 supplement, which ranks the largest ... [Published Rochester Business Journal - Jul 25 2014]
First reported Jul 23 2014 - Updated Jul 23 2014 - 1 reports

Lavar Burnett

, as he slept in his rocking chair at his care center in Phoenix. Born May 8, 1919, he is survived by his son, Dana, two younger sisters (Avalon Perkins and Darlene Plumb) and five younger brothers (Earl, Gale, Gary, Neil and Gene Burnett). He was born ... [Published Eastern Arizona Courier - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Valeant-Allergan takeover struggle takes nasty turn

The ugly takeover battle between Valeant Pharmaceuticals and Allergan got even uglier Monday.Valeant said it had complained to regulators in Canada and the United States about what it says are false statements Allergan made about the sales of some ­Valeant ... [Published Minneapolis Star Tribune - Jul 22 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Valeant wants Allergan shareholders to see growth at Bausch & Lomb

Valeant ( $VRX ), which is trying to overcome resistance from the management of Allergan ( $AGN ) for its $53 billion buyout offer, has filed a new presentation with the SEC in preparation for an investor meeting. Refuting Allergan's contention that its ... [Published FiercePharma - Jul 18 2014]
First reported Jul 17 2014 - Updated Jul 18 2014 - 2 reports

This Could Be A Reason Why Valeant Wants To Buy Allergan As Soon As Humanly Possible

On Thursday pharmaceutical company Valeant did yet another presentation meant to sway Allergan shareholders toward a Valeant takeover, and a question at the end of the presentation regarding Basuch & Lomb — which Valeant acquired in May of 2013 — may ... [Published Business Insider - Jul 17 2014]
First reported Jul 15 2014 - Updated Jul 15 2014 - 1 reports

COMIDA OKs tax incentives of more than $6.3 million for B&L building

An entity of developers Laurence Glazer, Robert Morgan and David Flaum was approved Tuesday for tax incentives of more than $6.3 million for upgrades to the Bausch & Lomb Inc. headquarters.Clinton Court LLC will make payments in lieu of taxes on the property, ... [Published Rochester Business Journal - Jul 15 2014]
First reported Jul 14 2014 - Updated Jul 15 2014 - 3 reports

TearLab appoints Venkiteshwar VP, medical affairs

Mr. Seph Jensen reportsMANOJ VENKITESHWAR JOINS TEARLAB AS VP OF MEDICAL AFFAIRSTearLab Corp. has appointed Manoj S. Venkiteshwar, PhD, to its senior management team in the newly created position of vice-president of medical affairs.Dr. Venkiteshwar's ... [Published Stockwatch - Jul 14 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 3 reports

Allergan again criticises Valeant's business model

Allergan on Monday reiterated its concerns over suitor Valeant Pharmaceuticals' business model, highlighting the latter's "anaemic organic growth driven by unsustainable price increases, among other fundamental... issues." In an investor presentation ... [Published FirstWord Pharma - Jul 14 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 2 reports

From Google Glass to Amazon Fire? Parviz moves on

Babak Parviz, who has been widely credited for developingGoogle Glass, announced he’smoving to Amazon on his Google+ page for an undisclosed position. He confirmed the job change to CNET on Monday.Over the weekend, Parviz updated his Google+ bio with ... [Published Fortune - Jul 14 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

B&L recalls some eye ointment

Rochester Business JournalBausch & Lomb Inc. has voluntarily pulled some 880,000 tubes of its Muro 128 eye ointment off store shelves.The eye-care company pulled the product, an over-the-counter salve to treat corneal edema, after hearing consumer complaints ... [Published Rochester Business Journal - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 08 2014 - 2 reports

European Ophthalmic Devices Market Outlook to 2020: Led by Alcon, Carl Zeiss Meditec, AMO and Bausch & Lomb

The increasing incidence of ocular conditions such as cataracts will drive the demand for Intraocular lenses devices and Phacoemulsification consoles, reports iData Research. (PRWeb July 08, 2014) Read the full story at http://www.prweb.com/rel ... [Published Presskontakt.se - Jul 08 2014]
First reported Jul 03 2014 - Updated Jul 03 2014 - 3 reports

Bausch & Lomb Recalls 850k Tubes Of Eye Ointment

Eye health products company Bausch & Lomb has recalled about 850,000 tubes of Muro 128, an eye-care ointment, the Wall Street Journal said Thursday.Bausch & Lomb, owned by Canada-based Valeant Pharmaceuticals International Inc (VRX: Quote,VRX.TO: Quote), ... [Published RTTNews.com - Jul 03 2014]

Quotes

...Paul Ashton, President and CEO of pSivida. "Should ILUVIEN be approved by the FDA, we are entitled to a $25 million milestone payment from Alimera in addition to net profit payments on Alimera’s sales of ILUVIEN.”"
The complaints in these cases are substantially identical.  Infringement of U S Patent No. RE40,000 ( "Method of Treatment for Decreasing Mortality Resulting from Congestive Heart Failure" reissued January 8, 2008) based on defendants' manufacture and sale of a generic version of GSK's Coreg® (carvedilol, used to treat congestive heart...
"I am general management and business development experience, especially in the ... important contributions to the continued growth and success of ..."

More Content

All (187) | News (159) | Reports (0) | Blogs (22) | Audio/Video (0) | Fact Sheets (3) | Press Releases (3)
sort by: Date | Relevance
pSivida Corp Announces Iluvien® Receives Market... [Published BioSpace - 58 mins ago]
Pennington adds business officer [Published The Advocate - 13 hours ago]
PSIVIDA : Announces ILUVIEN® Receives Marketing... [Published 4 Traders - 21 hours ago]
Aurobindo, Lupin being sued on generics plans [Published Financial Chronicle - 22 hours ago]
Court Report - July 2014 #3 [Published JD Supra - Jul 28 2014]
Lenskart.com signs up as team partner for Pro K... [Published Prlog - Jul 28 2014]
Baggy Eyes Serum Review Posted for Men and Wome... [Published Bio-Medicine - Jul 28 2014]
Wegmans is most-admired business [Published Rochester Business Journal - Jul 25 2014]
Second to none [Published Rochester Business Journal - Jul 25 2014]
Transparency Market Research: Global Eyewear Ma... [Published Minyanville - Jul 24 2014]
Lavar Burnett [Published Eastern Arizona Courier - Jul 23 2014]
Allergan Reiterates Plan to Preempt Valeant Offer [Published TheStreet.com - Jul 22 2014]
Allergan Reiterates Plan to Preempt Valeant Offer [Published The Street Latest - Jul 22 2014]
Lelon E. 'Lee' Schmidt [Published QC Times - Jul 22 2014]
Allergan cuts jobs to avoid hostile takeover by... [Published BDlive - Jul 22 2014]
Lelon Schmidt [Published Cedar Rapids Gazette - Jul 22 2014]
Valeant-Allergan takeover struggle takes nasty ... [Published Minneapolis Star Tribune - Jul 22 2014]
Allergan's (AGN) CEO David Pyott on Q2 2014 Res... [Published Seeking Alpha - Jul 21 2014]
First on CNBC: CNBC Transcript: Bill Ackman, Ma... [Published CNBC - Jul 21 2014]
Role changes for AbbVie and Shire CEOs after me... [Published In-Pharmatechnologist - Jul 21 2014]
Botox Maker Plans Deep Job Cuts During Takeover... [Published BusinessWeek - Jul 21 2014]
Valeant files complaints against Allergan for o... [Published Rochester Business Journal - Jul 21 2014]
Allergan to Cut About 1,500 Jobs to Evade Valea... [Published Washington Post - Jul 21 2014]
TSX drops as Ukraine, Gaza conflicts escalate; ... [Published Proactive Investors USA - Jul 21 2014]
TSX Edges Lower Amid Overseas Tensions [Published RTTNews.com - Jul 21 2014]
Allergan's largest shareholder sells stake in B... [Published UPI - Jul 21 2014]
Allergan reports higher Q2 net and sales, to cu... [Published Proactive Investors USA - Jul 21 2014]
Allergan Chops 1,500 Jobs to Fend Off Valeant [Published 24/7 Wall St - Jul 21 2014]
Diamond Packaging Wins Benny Award for '14 Appl... [Published Special Chem 4 Coatings - Jul 21 2014]
Valeant Ratchets Up War With Allergan [Published 24/7 Wall St - Jul 21 2014]
1 2 3 4 5 6 7
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Allergan To Cut 1,500 Jobs (AGN, VRX) [Published Clusterstock - Jul 21 2014]
Allergan is cutting jobs. Along with its second quarter earnings results this morning, Allergan announced "stockholder value enhancements," which include cutting 1,500 jobs, or approximately 13% of its current global headcount, and eliminate approximately ...
[tt] John Brooks: Xerox Xerox Xerox Xerox [Published TranshumanTech - Jul 20 2014]
This is a chapter from Bill Gates's favorite business book.Xerox Xerox Xerox XeroxChapter 5 in Business Adventures by John BrooksFirst appeared in the 1967 April Fool's Day issue of The New YorkerWHEN THE ORIGINAL mimeograph machine--the frst mechanical ...
This Could Be A Reason Why Valeant Wants To Buy... [Published Clusterstock - Jul 17 2014]
On Thursday pharmaceutical company Valeant did yet another presentation meant to sway Allergan shareholders toward a Valeant takeover, and a question at the end of the presentation regarding Basuch & Lomb — which Valeant acquired in May of 2013 — may ...
Diamond Packaging Wins Highest Honor in 65th An... [Published PR.com Press Releases - Jul 17 2014]
Rochester, NY, July 17, 2014 --( PR.com )-- Diamond Packaging today announced that it won two awards, including a Benny Award, the competition’s highest honor, in the 2014 Premier Print Awards, the graphic arts industry’s largest and most prestigious ...
Why Even Valeant’s Sweetened Deal Is Bad for Al... [Published Wall St. Cheat Sheet - Jun 03 2014]
Source: Thinkstock Last week, Valeant Pharmaceuticals  ( NYSE:VRX ) raised its bid for rival drugmaker Allergan Inc. ( NYSE:AGN ), perhaps best known for being the maker of the injectable skin treatment Botox, in an unusual move that has disappointed ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
European Ophthalmic Devices Market Outlook to 2... [Published GlobeNewswire: Acquisitions News - Jul 08 2014]
Magrabi Optical Offers Limited Ray-Ban Aviator ... [Published PR Newswire - Jan 06 2014]
Glenmark Announces Appointment of Mr. Philip An... [Published PR Newswire - Dec 02 2013]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.